Cargando…

Is Combination Antiviral Therapy Mandatory for Maintenance Therapy in Fully Suppressed Multidrug-Resistant Hepatitis B Patients?

AIM: The efficacy of tenofovir disoproxil fumarate (TDF) monotherapy as maintenance therapy in multidrug-resistant (MDR) hepatitis B virus (HBV) patients after complete virologic suppression (CVS) has not been well evaluated. We evaluated the efficacy of maintenance TDF monotherapy compared with con...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chung, Sung Won, Chang, Young, Lee, Hyo Young, Cho, Eun Ju, Lee, Jeong-Hoon, Yu, Su Jong, Yoon, Jung-Hwan, Kim, Yoon Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6311770/ https://www.ncbi.nlm.nih.gov/pubmed/30647735 http://dx.doi.org/10.1155/2018/6948235

Ejemplares similares

Antiviral efficacies of currently available rescue therapies for multidrug-resistant chronic hepatitis B
por: Park, Mi Sung, et al.
Publicado: (2013)

Long term outcome of antiviral therapy in patients with hepatitis B associated decompensated cirrhosis
por: Ju, Young-Cheol, et al.
Publicado: (2018)

Sofosbuvir-based therapy for patients with chronic hepatitis C: Early experience of its efficacy and safety in Korea
por: Cho, Yuri, et al.
Publicado: (2015)

Combination of Pegylated Interferon and Nucleos(t)ide Therapy: Toward a Cure of Hepatitis B Virus Infection?
por: Cho, Eun Ju, et al.
Publicado: (2016)

Correlation between Results of Semi-Quantitative and Quantitative Tests for Hepatitis B Virus Surface Antigen among Patients Achieving Viral Suppression with Antiviral Treatment
por: Chung, Goh Eun, et al.
Publicado: (2022)

Efficacy of Antiviral Prophylaxis up to 6 or 12 Months From Completion of Rituximab in Resolved Hepatitis B Patients: A Multicenter, Randomized Study
por: Jang, Heejoon, et al.
Publicado: (2023)

Maintenance interferon therapy in chronic hepatitis C patients who failed initial antiviral therapy: A meta-analysis
por: Hung, Hung-Chang, et al.
Publicado: (2019)

Independent Risk Factors for Hepatocellular Carcinoma Recurrence after Direct-Acting Antiviral Therapy in Patients with Chronic Hepatitis C
por: Ahn, Young-Hwan, et al.
Publicado: (2021)

Current Antiviral Therapy for Chronic Hepatitis B
por: Lim, Young-Suk, et al.
Publicado: (2004)

Hepatitis B Virus-Related Glomerulonephritis: Not a Predominant Cause of Proteinuria in Korean Patients with Chronic Hepatitis B
por: Yoo, Jeong-Ju, et al.
Publicado: (2015)

Low Incidence of Hepatocellular Carcinoma after Antiviral Therapy in Patients with Chronic Hepatitis C and Hemophilia
por: Kim, In Jung, et al.
Publicado: (2022)

Predictive validation of qualitative fibrosis staging in patients with chronic hepatitis B on antiviral therapy
por: Lee, Hye Won, et al.
Publicado: (2019)

Hepatic Steatosis Index in the Detection of Fatty Liver in Patients with Chronic Hepatitis B Receiving Antiviral Therapy
por: Chang, Jin Won, et al.
Publicado: (2021)

Effect of antiviral therapy in reducing perinatal transmission of hepatitis B virus and maternal outcomes after discontinuing them
por: Seo, Kwang Il, et al.
Publicado: (2018)

Validation of P2/MS for reflecting hepatic fibrosis in patients with hepatocellular carcinoma
por: Yu, Su Jong, et al.
Publicado: (2010)

Benefits and Risks of Antiviral Treatment during Pregnancy in Patients with Chronic Hepatitis B
por: Lee, Yoon Seok, et al.
Publicado: (2021)

Maintenance Therapy of Facial Seborrheic Dermatitis with 0.1% Tacrolimus Ointment
por: Kim, Hye One, et al.
Publicado: (2015)

Modified AS1411 Aptamer Suppresses Hepatocellular Carcinoma by Up-Regulating Galectin-14
por: Cho, Yuri, et al.
Publicado: (2016)

Systematic Review with Meta-Analysis: Comparison of the Risk of Hepatocellular Carcinoma in Antiviral-Naive Chronic Hepatitis B Patients Treated with Entecavir versus Tenofovir: The Devil in the Detail
por: Oh, Hyunwoo, et al.
Publicado: (2022)

Comparison of the Efficacy of Entecavir and Tenofovir in Nucleos(T)ide Analogue-Experienced Chronic Hepatitis B Patients
por: Cho, Eun Ju, et al.
Publicado: (2015)

Long-Term Prediction Model for Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Receiving Antiviral Therapy: Based on Data from Korean Patients
por: Lee, Ji Hun, et al.
Publicado: (2022)

The Effect of Antiviral Therapy on Serum Cholesterol Levels in Chronic Hepatitis C
por: Jang, Eun Sun, et al.
Publicado: (2011)

Long-term Nucleotide Analogue Treatment Has Higher Levels of Renal Toxicities than Does Entecavir in Patients with Chronic Hepatitis B
por: Cho, Young Youn, et al.
Publicado: (2020)

Intratumoral Photodynamic Therapy With Newly Synthesized Pheophorbide a in Murine Oral Cancer
por: Ahn, Mee-Young, et al.
Publicado: (2017)

Effects of Antiviral Therapy and Glucocorticoid Therapy on Fever Duration in Pediatric Patients with Influenza
por: Han, Ji Yoon, et al.
Publicado: (2021)

Quantitative Measurement of Hepatic Fibrosis with Gadoxetic Acid-Enhanced Magnetic Resonance Imaging in Patients with Chronic Hepatitis B Infection: A Comparative Study on Aspartate Aminotransferase to Platelet Ratio Index and Fibrosis-4 Index
por: Lee, Guy Mok, et al.
Publicado: (2017)

Tenofovir has inferior efficacy in adefovir-experienced chronic hepatitis B patients compared to nucleos(t)ide-naïve patients
por: Chung, Goh Eun, et al.
Publicado: (2017)

Effect of direct-acting antivirals for hepatitis C virus-related hepatocellular carcinoma recurrence and death after curative treatment
por: Ahn, Young-Hwan, et al.
Publicado: (2022)

Update on the Evidence Regarding Maintenance Therapy
por: Lee, Jeong Eun, et al.
Publicado: (2014)

Tenofovir-associated nephrotoxicity in patients with chronic hepatitis B: two cases
por: Cho, Hyeki, et al.
Publicado: (2016)

Inhibition of PI3K/Akt signaling suppresses epithelial-to-mesenchymal transition in hepatocellular carcinoma through the Snail/GSK-3/beta-catenin pathway
por: Lee, Seulki, et al.
Publicado: (2020)

Oral Medications Enhance Adherence to Surveillance for Hepatocellular Carcinoma and Survival in Chronic Hepatitis B Patients
por: Nam, Joon Yeul, et al.
Publicado: (2017)

A Clear Liquid Diet Is Not Mandatory for Polyethylene Glycol-Based Bowel Preparation for Afternoon Colonoscopy in Healthy Outpatients
por: Jung, Yoon Suk, et al.
Publicado: (2013)

Interim Guidelines on Antiviral Therapy for COVID-19
por: Kim, Sun Bean, et al.
Publicado: (2020)

Percutaneous ethanol injection therapy is comparable to radiofrequency ablation in hepatocellular carcinoma smaller than 1.5 cm: A matched case–control comparative analysis
por: Yu, Su Jong, et al.
Publicado: (2016)

Early Normalization of Alanine Aminotransferase during Antiviral Therapy Reduces Risk of Hepatocellular Carcinoma in HBV Patients
por: Kim, Sehwa, et al.
Publicado: (2021)

Predictors of COVID-19 booster vaccine hesitancy among fully vaccinated adults in Korea: a nationwide cross-sectional survey
por: Noh, Yunha, et al.
Publicado: (2022)

Antiviral therapy in neonatal cholestatic cytomegalovirus hepatitis
por: Ozkan, Tanju Basarir, et al.
Publicado: (2007)

Antiviral therapy for chronic hepatitis B in China
por: Zheng, Xin, et al.
Publicado: (2014)

Comprehensive mandatory policies are needed to fully protect all children from unhealthy food marketing
por: Dillman Carpentier, Francesca R., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0e85pell4tofv564c0neniul9f